Wellsmont Group consulting services focused on advancing the impact of precision medicine in healthcare.

Our consulting services and strategic planning can vary across the different phases of precision medicine.

• Early entrants in precision medicine can align proposed solutions with competitive landscape assessment and standard of care algorithms.

• Development of new laboratory testing methods and disease profiling can be aligned with current standards of laboratory medicine. The new evidence can be reviewed against clinical utility requirements, proposed intended uses, and stakeholder feedback to create a customized clinical evidence generation plan and publication strategy.

• Validated solutions can be positioned for early adopter evaluation, stakeholder engagement, clinical utility trials, regulatory consideration and submission, health economic outcomes analysis, and decision impact studies.